Medical Director

Summary

Join QED Therapeutics, a BridgeBio Pharma affiliate, as their Medical Director, Medical Affairs. Reporting to the Head of Medical Affairs, you will play a crucial role in the pre-launch and launch activities of infigratinib for achondroplasia and hypochondroplasia. This role involves developing medical content, leading advisory board meetings, engaging with key opinion leaders, and collaborating with internal and external stakeholders. You will be responsible for medical affairs strategy and tactics, including post-marketing commitments and medical reviews. The position is remote but US-based, with up to 40% domestic and international travel. Success in this role requires strong medical affairs experience, leadership skills, and a collaborative approach.

Requirements

• MD, PhD, or PharmD with 3 or more years of post-graduate experience
• At least 3 years (or more) of post-graduate US medical affairs experience in a pharmaceutical or biotechnology company are needed
• Solid understanding of the process of pharmaceutical product development and approval is needed
• Experience at successfully launching a biopharmaceutical asset in the USA is a must
• Experience in medical affairs strategy and development of medical affairs plans is necessary
• Demonstrated ability to effectively execute medical affairs tactics on time and budget is needed
• Knowledge of US regulations impacting Medical Affairs and Field Medical activities in the pharmaceutical industry is critical
• Demonstrated ability to organize, prioritize, and execute work in a fast-paced environment with minimal supervision is needed
• Excellent written and verbal communication skills
• Ability to travel domestically and internationally, up to 40% of the time to attend scientific meetings, advisory boards, and other venues as needed. Travel will include overnight stays and weekend work based upon business needs
• Team player who effectively collaborates with people of diverse educational, cultural and professional backgrounds
• Consensus seeker who knows how to lead and contribute without direct authority

Responsibilities

• Develop medical content to educate HCPs, advocates and internal stakeholders on achondroplasia, hypochondroplasia and infigratinib
• Lead or co-lead advisory board meetings and symposia to support infigratinib
• Responsible for engagement with clinical consultants, Key Opinion Leaders (KOLs) and the research community to support the company’s initiatives
• Responsible for developing a training curriculum for new hires or new team members, MSLs, sales and marketing colleagues and other internal colleagues
• Medical reviewer and approver for Medical and Commercial content as the Medical Affairs representative at BrideBio’s MLR (Medical , Legal and Regulatory Review Committee) for achondroplasia, hypochondroplasia and infigratinib
• Collaborate with HEOR in health economics and burden of disease initiatives
• Co-develop Field Medical strategy and tactics in partnership with the Field Medical/MSL Team
• Collaborate with clinical development on ongoing and planned clinical trials (phase 2-4)
• Collaborate with clinical development and other cross - functional teams to establish scientific data dissemination strategies to support registration and launch activities
• Support patient advocacy team in development and review of patient and advocacy initiatives
• Represent company at scientific, clinical, and professional organizations meetings
• Collaborate with Scientific Communications to prepare publications and presentations for external meetings
• Function as the medical representative at cross-functional and project teams meetings
• Additional responsibilities as needed

Preferred Qualifications

• Experience in rare diseases is a plus
• Experience in endocrinology or pediatric endocrinology is desired
• Clinical and patient management experience is a plus
• Understanding US payor and reimbursement landscape is desired

Benefits

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion